Bulk Manufacturer of Controlled Substances Application: Curia New York, Inc, 71022-71023 [2023-22624]
Download as PDF
<![CDATA[
71022
Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices
Controlled substance
Drug code
Fentanyl ...........................................................................................................................................................................
The company plans to bulk
manufacture the listed controlled
substances in bulk for distribution and
sale to its customers. In reference to
drug codes 7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as a synthetic. No other activities for
these drug codes are authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
manufacturing of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–22627 Filed 10–12–23; 8:45 am]
BILLING CODE P
[FR Doc. 2023–22623 Filed 10–12–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
[Docket No. DEA–1271]
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotope Laboratories, Inc
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cambridge Isotope
Laboratories, Inc has applied to be
registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 12, 2023. Such
persons may also file a written request
for a hearing on the application on or
before December 12, 2023.
SUMMARY:
Drug code
lotter on DSK11XQN23PROD with NOTICES1
[Docket No. DEA–1273]
Bulk Manufacturer of Controlled
Substances Application: Curia New
York, Inc
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Curia New York, Inc has
applied to be registered as a bulk
SUMMARY:
VerDate Sep<11>2014
16:55 Oct 12, 2023
Jkt 262001
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 12, 2023. Such
persons may also file a written request
for a hearing on the application on or
before December 12, 2023.
DATES:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
ADDRESSES:
PO 00000
Frm 00103
Fmt 4703
Sfmt 4703
II
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 25, 2023,
Cambridge Isotope Laboratories, Inc 50
Frontage Road, Andover, Massachusetts
01810–5413, applied to be registered as
a bulk manufacturer of the following
basic class(es) of controlled
substance(s):
Tetrahydrocannabinols ............................................................................................................................................
Claude Redd,
Acting Deputy Assistant Administrator.
9801
ADDRESSES:
DEPARTMENT OF JUSTICE
Controlled substance
The company plans to synthetically
bulk manufacture the controlled
substance Tetrahydrocannabinols to
produce analytical standards for
distribution to its customers. No other
activities for this drug code is
authorized for this registration.
Schedule
7370
Schedule
I
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on August 10, 2023, Curia
New York, Inc, 33 Riverside Avenue,
Rensselaer, New York 12144–2951,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Drug
code
Schedule
Marihuana ...................................
Tetrahydrocannabinols ...............
Amphetamine ..............................
Lisdexamfetamine .......................
Methylphenidate ..........................
Pentobarbital ...............................
Codeine .......................................
Dihydrocodeine ...........................
Oxycodone ..................................
Hydromorphone ..........................
Hydrocodone ...............................
Meperidine ..................................
Morphine .....................................
7360
7370
1100
1205
1724
2270
8333
9050
9143
9150
9193
9230
9300
I
I
II
II
II
II
II
II
II
II
II
II
II
E:\FR\FM\13OCN1.SGM
13OCN1
71023
Federal Register / Vol. 88, No. 197 / Friday, October 13, 2023 / Notices
Drug
code
Schedule
DEPARTMENT OF JUSTICE
Fentanyl ......................................
9801
II
Drug Enforcement Administration
[Docket No. DEA–1268]
The company plans to manufacture
the above controlled substances as bulk
active pharmaceutical ingredients for
use in product development and for
distribution to its customers. In
reference to drug codes 7360
(Marihuana), and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetic. No other activities for these
drug codes are authorized for this
registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023–22624 Filed 10–12–23; 8:45 am]
BILLING CODE P
Bulk Manufacturer of Controlled
Substances Application: Cerilliant
Corporation
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Cerilliant Corporation, has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before December 12, 2023. Such
persons may also file a written request
for a hearing on the application on or
before December 12, 2023.
SUMMARY:
The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on July 12, 2023, Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78665–2402,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
ADDRESSES:
Controlled substance
lotter on DSK11XQN23PROD with NOTICES1
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3-FMC) ....................................................................................................................................
Cathinone ..............................................................................................................................................................................
Para-Methoxymethamphetamine (PMMA), 1-(4-1245 I N methoxyphenyl)-N-methylpropan-2-amine .................................
Methcathinone .......................................................................................................................................................................
4-Fluoro-N-methylcathinone (4-FMC) ....................................................................................................................................
Pentedrone (a-methylaminovalerophenone) .........................................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ..........................................................................................................................
4-Methyl-N-ethylcathinone (4-MEC) ......................................................................................................................................
Naphyrone .............................................................................................................................................................................
N-Ethylamphetamine .............................................................................................................................................................
N,N-Dimethylamphetamine ....................................................................................................................................................
Fenethylline ...........................................................................................................................................................................
Aminorex ................................................................................................................................................................................
4-Methylaminorex (cis isomer) ..............................................................................................................................................
4,4′-Dimethylaminorex (4,4′-DMAR; 4,5-dihydro-4-1595 I N methyl-5-(4-methylphenyl)-2-oxazolamine; 4-methyl-5-(4methylphenyl)-4,5-dihydro-1,3-oxazol-2-amine).
Gamma Hydroxybutyric Acid .................................................................................................................................................
Methaqualone ........................................................................................................................................................................
Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine ......................................
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) .................................
Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo [f][1,2,4]triazolo[4,3-a][1,4]diazepine .......................................
Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine ................................
Diclazepam (7-chloro-5-(2-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one ......................
JWH-250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) .........................................................................................................
SR-18 (Also known as RCS-8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) .......................................................
ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ...................
5-Fluoro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .......................
AB-FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) ............................
FUB-144 (1-(4-fluorobenzyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone) .....................................................
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) .............................................................................................................................
MDMB-FUBINACA (Methyl 2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .............................
FUB-AMB, MMB-FUBINACA, AMB-FUBINACA (2-(1-(4-fluorobenzyl)-1Hindazole-3-carboxamido)-3-methylbutanoate) ...
AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ................................................
THJ-2201 ([1-(5-fluoropentyl)-1H-indazol-3-yl](naphthalen-1-yl)methanone) .......................................................................
5F-AB-PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluropentyl)-1H-indazole-3-carboximide) ...............................
AB-CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ......................
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide) ...............
5F-AMB (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3-methylbutanoate) .....................................................
5F-ADB, 5F-MDMB-PINACA (Methyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) ..............
ADB-PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) ........................................
5F-EDMB-PINACA (ethyl 2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate) .................................
5F-MDMB-PICA (methyl 2-(1-(5-fluoropentyl)-1H-indole-3-carboxamido)-3,3-dimethylbutanoate) ......................................
VerDate Sep<11>2014
16:55 Oct 12, 2023
Jkt 262001
PO 00000
Frm 00104
Fmt 4703
Sfmt 4703
E:\FR\FM\13OCN1.SGM
13OCN1
Schedule
1233
1235
1245
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
1595
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
2010
2565
2780
2785
2786
2788
2789
6250
7008
7010
7011
7012
7014
7019
7020
7021
7023
7024
7025
7031
7032
7033
7034
7035
7036
7041
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 88, Number 197 (Friday, October 13, 2023)]
[Notices]
[Pages 71022-71023]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22624]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1273]
Bulk Manufacturer of Controlled Substances Application: Curia New
York, Inc
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Curia New York, Inc has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
December 12, 2023. Such persons may also file a written request for a
hearing on the application on or before December 12, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 10, 2023, Curia New York, Inc, 33 Riverside
Avenue, Rensselaer, New York 12144-2951, applied to be registered as a
bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana................................ 7360 I
Tetrahydrocannabinols.................... 7370 I
Amphetamine.............................. 1100 II
Lisdexamfetamine......................... 1205 II
Methylphenidate.......................... 1724 II
Pentobarbital............................ 2270 II
Codeine.................................. 8333 II
Dihydrocodeine........................... 9050 II
Oxycodone................................ 9143 II
Hydromorphone............................ 9150 II
Hydrocodone.............................. 9193 II
Meperidine............................... 9230 II
Morphine................................. 9300 II
[[Page 71023]]
Fentanyl................................. 9801 II
------------------------------------------------------------------------
The company plans to manufacture the above controlled substances as
bulk active pharmaceutical ingredients for use in product development
and for distribution to its customers. In reference to drug codes 7360
(Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to
bulk manufacture these drugs as synthetic. No other activities for
these drug codes are authorized for this registration.
Claude Redd,
Acting Deputy Assistant Administrator.
[FR Doc. 2023-22624 Filed 10-12-23; 8:45 am]
BILLING CODE P
